tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TPST Stock Latest News

Tempest Therapeutics appoints Sheldon Mullins as VP, regulatory affairs
The FlyTempest Therapeutics appoints Sheldon Mullins as VP, regulatory affairs
2d ago
TPST
Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PremiumPress Releases
Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference
15d ago
TPST
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27d ago
TPST
Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance
PremiumPress Releases
Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance
30d ago
TPST
Tempest Therapeutics appoints Troy Wagner as VP, quality assurance
PremiumThe Fly
Tempest Therapeutics appoints Troy Wagner as VP, quality assurance
30d ago
TPST
Tempest announces feedback form End-of-Phase 2 meeting with FDA for TPST-1120
PremiumThe FlyTempest announces feedback form End-of-Phase 2 meeting with FDA for TPST-1120
1M ago
TPST
Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma
Premium
Press Releases
Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma
1M ago
TPST
TPST Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
TPST Upcoming Earnings Report: What to Expect?
1M ago
TPST
Tempest Therapeutics reports Q2 EPS (42c), consensus (40c)
PremiumThe Fly
Tempest Therapeutics reports Q2 EPS (42c), consensus (40c)
1M ago
TPST
Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update
1M ago
TPST
Tempest Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Tempest Therapeutics files $300M mixed securities shelf
2M ago
TPST
Tempest Therapeutics unveils new survival data for amezalpat
PremiumThe Fly
Tempest Therapeutics unveils new survival data for amezalpat
3M ago
TPST
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
PremiumPress ReleasesTempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
3M ago
TPST
Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma
Premium
Press Releases
Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma
3M ago
TPST
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Premium
Press Releases
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
3M ago
TPST
Tempest Therapeutics reports Q1 EPS (36c), consensus (37c)
PremiumThe Fly
Tempest Therapeutics reports Q1 EPS (36c), consensus (37c)
4M ago
TPST
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
4M ago
TPST
Is TPST a Buy, Before Earnings?
PremiumPre-Earnings
Is TPST a Buy, Before Earnings?
5M ago
TPST
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
5M ago
TPST
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
5M ago
GCT
IWM
Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
Premium
Press Releases
Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
5M ago
TPST
Tempest presents data showing PST-1120 reduces RCC growth as a monotherapy
Premium
The Fly
Tempest presents data showing PST-1120 reduces RCC growth as a monotherapy
5M ago
TPST

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >